Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 4
2019 5
2020 5
2021 4
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function.
Jensen SBK, Juhl CR, Janus C, Lundgren JR, Martinussen C, Wiingaard C, Knudsen C, Frikke-Schmidt R, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS. Jensen SBK, et al. Among authors: martinussen c. Obesity (Silver Spring). 2023 Apr;31(4):977-989. doi: 10.1002/oby.23715. Obesity (Silver Spring). 2023. PMID: 36942420 Clinical Trial.
Emerging drugs for the treatment of obesity.
Martinussen C, Bojsen-Moller KN, Svane MS, Dejgaard TF, Madsbad S. Martinussen C, et al. Expert Opin Emerg Drugs. 2017 Mar;22(1):87-99. doi: 10.1080/14728214.2017.1269744. Epub 2016 Dec 16. Expert Opin Emerg Drugs. 2017. PMID: 27927032 Review.
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Bojsen-Møller KN, Svane MS, Martinussen C, Dirksen C, Jørgensen NB, Jensen JB, Jensen CZ, Torekov SS, Kristiansen VB, Rehfeld JF, Bork-Jensen J, Grarup N, Hansen T, Hartmann B, Holst JJ, Madsbad S. Bojsen-Møller KN, et al. Among authors: martinussen c. Int J Obes (Lond). 2023 Nov;47(11):1143-1151. doi: 10.1038/s41366-023-01372-8. Epub 2023 Aug 31. Int J Obes (Lond). 2023. PMID: 37653071 Free PMC article.
The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery.
Hindsø M, Hedbäck N, Svane MS, Møller A, Martinussen C, Jørgensen NB, Dirksen C, Gasbjerg LS, Kristiansen VB, Hartmann B, Rosenkilde MM, Holst JJ, Madsbad S, Bojsen-Møller KN. Hindsø M, et al. Among authors: martinussen c. Diabetes. 2023 Mar 1;72(3):336-347. doi: 10.2337/db22-0568. Diabetes. 2023. PMID: 36478039
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty.
Svane MS, Øhrstrøm CC, Plamboeck A, Jørgensen NB, Bojsen-Møller KN, Dirksen C, Martinussen C, Vilsbøll T, Hartmann B, Deacon CF, Kristiansen VB, Knop FK, Svendsen LB, Madsbad S, Holst JJ, Veedfald S. Svane MS, et al. Among authors: martinussen c. Neurogastroenterol Motil. 2022 Jan;34(1):e14210. doi: 10.1111/nmo.14210. Epub 2021 Aug 11. Neurogastroenterol Motil. 2022. PMID: 34378827
Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
Wewer Albrechtsen NJ, Møller A, Martinussen C, Gluud LL, Rashu EB, Richter MM, Plomgaard P, Goetze JP, Kjeldsen S, Hansen LH, Gustafsson F, Deacon CF, Holst JJ, Madsbad S, Bojsen-Møller KN. Wewer Albrechtsen NJ, et al. Among authors: martinussen c. Diabetes Obes Metab. 2022 Oct;24(10):2017-2026. doi: 10.1111/dom.14789. Epub 2022 Jul 21. Diabetes Obes Metab. 2022. PMID: 35676803 Free PMC article. Clinical Trial.
Effect of bariatric surgery on plasma GDF15 in humans.
Kleinert M, Bojsen-Møller KN, Jørgensen NB, Svane MS, Martinussen C, Kiens B, Wojtaszewski JFP, Madsbad S, Richter EA, Clemmensen C. Kleinert M, et al. Among authors: martinussen c. Am J Physiol Endocrinol Metab. 2019 Apr 1;316(4):E615-E621. doi: 10.1152/ajpendo.00010.2019. Epub 2019 Feb 5. Am J Physiol Endocrinol Metab. 2019. PMID: 30721097 Free article.
GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.
Gabe MBN, Skov-Jeppesen K, Gasbjerg LS, Schiellerup SP, Martinussen C, Gadgaard S, Boer GA, Oeke J, Torz LJ, Veedfald S, Svane MS, Bojsen-Møller KN, Madsbad S, Holst JJ, Hartmann B, Rosenkilde MM. Gabe MBN, et al. Among authors: martinussen c. Pharmacol Res. 2022 Feb;176:106058. doi: 10.1016/j.phrs.2022.106058. Epub 2022 Jan 4. Pharmacol Res. 2022. PMID: 34995796 Clinical Trial.
29 results